Cures Within Reach funds clinical trials using AI to validate repurposed therapies for unsolved diseases, prioritizing rare conditions and explainable AI workflows.
Repurposing Research for Chicago 2026: Track 2 – Patient Groups supports Chicago-area researchers testing existing therapies for unsolved diseases in underserved groups, children, rare disease patients, and military groups.
Use mouse models to test existing and investigational drugs for Alzheimer's; focus on drug repositioning and combo therapy development.
2026 ReGRoW supports underresourced researchers in low and lower-middle income countries to test repurposed therapies for unsolved diseases, seeking affordable treatments and stronger local research capacity.
ALS Finding a Cure funds research using AI and NLP to advance ALS diagnostics, biomarker discovery, disease modeling, and therapeutic innovation.
Repurposing Generic (ReGen) Drugs Evidence Package Challenge supports individuals, teams, and entities developing evidence for new generic drug uses in high-cost conditions to advance access to affordable treatments.